Cross-Species Transcriptional Network Analysis Defines Shared Inflammatory Responses in Murine and Human Lupus Nephritis
暂无分享,去创建一个
Matthias Kretzler | Viji Nair | E. Bottinger | V. Nair | C. Cohen | M. Kretzler | S. Segerer | C. Berthier | Weijia Zhang | M. Lindenmeyer | A. Davidson | Stephan Segerer | T. González-Rivera | Clemens D Cohen | Meera Ramanujam | Celine C Berthier | Anne Davidson | Erwin P Bottinger | Weijia Zhang | Ramalingam Bethunaickan | Tania Gonzalez-Rivera | Maja Lindenmeyer | M. Ramanujam | R. Bethunaickan | Weijia Zhang
[1] Eric Thervet,et al. Outcome of relapse in lupus nephritis: roles of reversal of renal fibrosis and response of inflammation to therapy. , 2002, Kidney international.
[2] S. Segerer,et al. Dendritic Cells in Human Renal Inflammation – Part II , 2011, Nephron Experimental Nephrology.
[3] J. Duffield. Macrophages and immunologic inflammation of the kidney. , 2010, Seminars in nephrology.
[4] T. Utset,et al. Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring , 2011, Arthritis care & research.
[5] L. Davis,et al. Dysregulated expression of CXCR4/CXCL12 in subsets of patients with systemic lupus erythematosus. , 2010, Arthritis and rheumatism.
[6] E. Bottinger,et al. Activated Renal Macrophages Are Markers of Disease Onset and Disease Remission in Lupus Nephritis1 , 2008, The Journal of Immunology.
[7] C. Cohen,et al. Compartment specific expression of dendritic cell markers in human glomerulonephritis. , 2008, Kidney international.
[8] Xuejun Liu,et al. Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli. , 2004, The Journal of clinical investigation.
[9] D. Ferenbach,et al. Macrophages and dendritic cells: what is the difference? , 2008, Kidney international.
[10] Felix Eichinger,et al. Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. , 2007, Journal of the American Society of Nephrology : JASN.
[11] C. Hughes,et al. Of Mice and Not Men: Differences between Mouse and Human Immunology , 2004, The Journal of Immunology.
[12] M. Madaio,et al. Short Term Administration of Costimulatory Blockade and Cyclophosphamide Induces Remission of Systemic Lupus Erythematosus Nephritis in NZB/W F1 Mice by a Mechanism Downstream of Renal Immune Complex Deposition , 2003, The Journal of Immunology.
[13] R. Evans,et al. PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation , 2001, Nature Medicine.
[14] G. Müller-Newen,et al. J Am Soc Nephrol 15: 613–621, 2004 Identification and Functional Characterization of Dendritic Cells in the Healthy Murine Kidney and in Experimental , 2003 .
[15] M. Ward. Changes in the Incidence of Endstage Renal Disease Due to Lupus Nephritis in the United States, 1996–2004 , 2008, The Journal of Rheumatology.
[16] M. Ward. Changes in the incidence of end-stage renal disease due to lupus nephritis, 1982-1995. , 2000, Archives of internal medicine.
[17] E. Bottinger,et al. Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis , 2008, The Journal of Immunology.
[18] E. Meffre,et al. In Situ B Cell-Mediated Immune Responses and Tubulointerstitial Inflammation in Human Lupus Nephritis , 2011, The Journal of Immunology.
[19] M. Madaio,et al. Prevention of murine antiphospholipid syndrome by BAFF blockade. , 2008, Arthritis and rheumatism.
[20] C. Cerletti,et al. Src-family kinases mediate an outside-in signal necessary for beta2 integrins to achieve full activation and sustain firm adhesion of polymorphonuclear leucocytes tethered on E-selectin. , 2006, The Biochemical journal.
[21] C. Mohan,et al. Systemic lupus erythematosus--recent clues from congenic strains. , 2005, Archivum immunologiae et therapiae experimentalis.
[22] D. Gladman,et al. Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity. , 2000, The Journal of rheumatology.
[23] W. Liang,et al. TM4 microarray software suite. , 2006, Methods in enzymology.
[24] P. Igarashi,et al. CXCR4/CXCL12 Hyperexpression Plays a Pivotal Role in the Pathogenesis of Lupus1 , 2009, The Journal of Immunology.
[25] S. Adler,et al. Upregulation of monocyte/macrophage HGFIN (Gpnmb/Osteoactivin) expression in end-stage renal disease. , 2010, Clinical journal of the American Society of Nephrology : CJASN.
[26] A. Theofilopoulos,et al. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains , 1978, The Journal of experimental medicine.
[27] A. Piccoli,et al. Long-term prognosis and causes of death in systemic lupus erythematosus. , 2006, The American journal of medicine.
[28] Sik Lee,et al. Distinct macrophage phenotypes contribute to kidney injury and repair. , 2011, Journal of the American Society of Nephrology : JASN.
[29] W. Liang,et al. 9) TM4 Microarray Software Suite , 2006 .
[30] B. Hoffman,et al. Deregulated c-Myc prematurely recruits both Type I and II CD95/Fas apoptotic pathways associated with terminal myeloid differentiation , 2002, Oncogene.
[31] M. Rastaldi,et al. The Detrimental Effects of IFN-α on Vasculogenesis in Lupus Are Mediated by Repression of IL-1 Pathways: Potential Role in Atherogenesis and Renal Vascular Rarefaction , 2010, The Journal of Immunology.
[32] Jignesh M. Patel,et al. TALE: A Tool for Approximate Large Graph Matching , 2008, 2008 IEEE 24th International Conference on Data Engineering.
[33] Michael Loran Dustin,et al. CX3CR1+ interstitial dendritic cells form a contiguous network throughout the entire kidney. , 2006, Kidney international.
[34] L. Fésüs,et al. PPARγ‐dependent regulation of human macrophages in phagocytosis of apoptotic cells , 2007, European journal of immunology.
[35] Yutaka Kobayashi,et al. Quantitative analysis of interstitial alterations in lupus nephritis , 2004, Virchows Archiv A.
[36] F. Dekker,et al. Survival Analysis I: The Kaplan-Meier Method , 2011, Nephron Clinical Practice.
[37] C. Mohan,et al. Targeting the CXCR4/CXCL12 axis in systemic lupus erythematosus , 2009, Expert opinion on therapeutic targets.
[38] S. McMahon,et al. Emerging Concepts in the Analysis of Transcriptional Targets of the MYC Oncoprotein: Are the Targets Targetable? , 2010, Genes & cancer.
[39] Ziv Bar-Joseph,et al. Cross Species Expression Analysis of Innate Immune Response , 2009, J. Comput. Biol..
[40] V. D’Agati,et al. Tubulointerstitial disease in lupus nephritis: relationship to immune deposits, interstitial inflammation, glomerular changes, renal function, and prognosis. , 1986, Nephron.
[41] M. Rastaldi,et al. Enhanced Expression of Janus Kinase–Signal Transducer and Activator of Transcription Pathway Members in Human Diabetic Nephropathy , 2009, Diabetes.
[42] J. Grande. Experimental models of lupus nephritis. , 2011, Contributions to nephrology.
[43] B. J. Helyer,et al. Renal Disease associated with Positive Lupus Erythematosus Tests in a Crossbred Strain of Mice , 1963, Nature.
[44] S. Segerer,et al. Dendritic Cells in Experimental Renal Inflammation – Part I , 2011, Nephron Experimental Nephrology.
[45] A. DeFranco,et al. Fcγ Receptor–Mediated Phagocytosis in Macrophages Lacking the Src Family Tyrosine Kinases Hck, Fgr, and Lyn , 2000, The Journal of experimental medicine.
[46] Michael L. Creech,et al. Integration of biological networks and gene expression data using Cytoscape , 2007, Nature Protocols.
[47] E. Bottinger,et al. A Unique Hybrid Renal Mononuclear Phagocyte Activation Phenotype in Murine Systemic Lupus Erythematosus Nephritis , 2011, The Journal of Immunology.
[48] D. Sanoudou,et al. Regulation of adverse remodelling by osteopontin in a genetic heart failure model. , 2012, European heart journal.
[49] C. Cohen,et al. Quantitative gene expression analysis in renal biopsies: a novel protocol for a high-throughput multicenter application. , 2002, Kidney international.
[50] T. Yamamoto,et al. Differential involvement of Src family kinases in Fc gamma receptor-mediated phagocytosis. , 2000, Journal of immunology.
[51] A. Davidson,et al. Targeting of the immune system in systemic lupus erythematosus , 2008, Expert Reviews in Molecular Medicine.
[52] A. Davidson,et al. Lupus nephritis: lessons from murine models , 2010, Nature Reviews Rheumatology.
[53] K. Walsh,et al. The Peroxisome Proliferator-Activated Receptor γ Agonist Rosiglitazone Ameliorates Murine Lupus by Induction of Adiponectin1 , 2009, The Journal of Immunology.
[54] B. Staels,et al. Regulation of Macrophage Functions by PPAR-&agr;, PPAR-&ggr;, and LXRs in Mice and Men , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[55] T. Kawakami,et al. Regulation of myeloproliferation and M2 macrophage programming in mice by Lyn/Hck, SHIP, and Stat5. , 2008, The Journal of clinical investigation.
[56] M. Madaio,et al. Selective blockade of BAFF for the prevention and treatment of systemic lupus erythematosus nephritis in NZM2410 mice. , 2010, Arthritis and rheumatism.
[57] A I Saeed,et al. TM4: a free, open-source system for microarray data management and analysis. , 2003, BioTechniques.
[58] R. Cantor,et al. Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus , 2010, Proceedings of the National Academy of Sciences.
[59] K. Coombes,et al. Identification and validation of biomarkers of IgV(H) mutation status in chronic lymphocytic leukemia using microfluidics quantitative real-time polymerase chain reaction technology. , 2007, The Journal of molecular diagnostics : JMD.
[60] F. Speleman,et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.
[61] F. Finkelman,et al. Differential Contribution of IL-4 and STAT6 vs STAT4 to the Development of Lupus Nephritis1 , 2003, The Journal of Immunology.
[62] Cheng Li,et al. Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.
[63] J. Duffield. Macrophages in kidney repair and regeneration. , 2011, Journal of the American Society of Nephrology : JASN.
[64] Felix Eichinger,et al. Modular Activation of Nuclear Factor-κB Transcriptional Programs in Human Diabetic Nephropathy , 2006, Diabetes.
[65] James L. Park,et al. The Peroxisome Proliferator-Activated Receptor γ Agonist Pioglitazone Improves Cardiometabolic Risk and Renal Inflammation in Murine Lupus1 , 2009, The Journal of Immunology.
[66] M. Madaio,et al. Short Term Administration of Costimulatory Blockade and Cyclophosphamide Induces Remission of Systemic Lupus Erythematosus Nephritis in NZB/W F1 Mice by a Mechanism Downstream of Renal Immune Complex Deposition1 , 2003, The Journal of Immunology.